Voiding and sexual dysfunction after cerebrovascular accidents

Journal of Urology

Volumn 165, Issue 2, 2001, Pages 359-370

  Marinkovic, Serge Peter ^a   Badlani, Gopal ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Cerebrovascular accident; Hyperreflexia; Urinary incontinence

Indexed keywords

CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONSERVATIVE TREATMENT; DETRUSOR DYSSYNERGIA; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MEDICAL INFORMATION; MICTURITION DISORDER; MORBIDITY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REVIEW; SEXUAL DYSFUNCTION; STROKE; SYMPTOM; URETHRA DISEASE; URGE INCONTINENCE; URINE INCONTINENCE; URODYNAMICS;

EID: 0035191136     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-200102000-00003     Document Type: Review

References (137)

1. Epidemiology of cerebrovascular disease
2. Cerebrovascular disorders
3. Stroke prevention
4. Cigarette smoking. A risk factor for cerebral infarction in young adults
5. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
6. Influence of hyperglycaemia on infarct size and clinical outcome of acute ischemic stroke patients with intracranial arterial occlusion
7. Use of Medicare claims data to estimate national trends in stroke incidence, 1985-1991
8. Decline in US stroke mortality. Demographic trends and antihypertensive treatment
9. Bladder dysfunction after a stroke - It's not always inevitable
10. Urologic problems in cerebrovascular accidents
11. Detrusor behavior in patients with dominant hemispheric strokes
12. Causes of urinary incontinence after acute hemispheric stroke
13. Predictive correlation of urodynamic dysfunction and brain injury after cerebrovascular accident
14. Predicting the disability of first-time stroke sufferers at 1 year. 12-Month follow-up of a population-based cohort in Southeast England
15. Outlook after an acute stroke: Urinary incontinence and loss of consciousness compared in 532 patients
16. The supraspinal control of the urinary bladder
17. Autonomic regulation of the urinary bladder and sexual organs
18. Innervation of the detrusor muscle and urethra
19. The physiology and pharmacology of urinary tract dysfunction
20. Neuroanatomy and physiology: Innervation of the urinary tract
21. Levels of the brainstem and diencephalon controlling micturition reflex
22. Localization of brainstem and diencephalic areas controlling the micturition reflex
23. The central nervous connections of the bladder
24. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours
25. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
26. Tissue plasminogen activator for acute ischemic stroke
27. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke
28. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: A randomized controlled trial
29. CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke
30. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes
31. Urgent therapy for stroke. Part. II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset
32. New therapies introduced at conference
33. The nervous control of the urinary bladder
34. Urinary incontinence after stroke: A prospective study
35. Effect of cerebellectomy on reflex micturition in the decerebrate dog as determined by urodynamic evaluation
36. Analysis of voiding disorders in patients with cerebrovascular accidents
37. Cerebrovascular accidents: Urodynamic and neuroanatomical findings
38. Urodynamic studies on hemiplegic patients after cerebrovascular accident
39. Acute cerebrovascular accident and lower urinary tract dysfunction: A prospective correlation of the site of brain injury with urodynamic findings
40. Results of prostatectomy in patients following a cerebrovascular accident
41. Cerebrovascular accidents. Urological effects and management
42. The neurophysiology of micturition: A clinical study of 550 patients
43. Etiologic possibilities for increased pelvic floor electromyography activity during cystometry
44. Micturitional disturbance after acute hemispheric stroke: Analysis of the lesion site by CT and MRI
45. Detrusor hyperreflexia in strokes
46. Male sexual function. Impairment after right hemisphere stroke
47. Urinary incontinence in the acute phase of cerebrovascular accident. A descriptive study of hospitalized patients
48. Incidence and correlates of incontinence in stroke patients
49. Factors affecting functional outcome after stroke: A critical review of rehabilitation interventions
50. Autonomic consequences of cerebral hemisphere infarction
51. Cardiovascular autonomic reflexes in brain infarction
52. Abnormal heart rate variability reflecting autonomic dysfunction in brainstem infarction
53. Reduced heart rate variability after right-sided stroke
54. Abnormal heart rate variability as a manifestation of autonomic dysfunction in hemispheric brain infarction
55. Hyperhidrosis as a reflection of autonomic failure in patients with acute hemispheral brain infarction. An evaporimetric study
56. Ipsilateral hypohidrosis in brain stem infarction
57. Asymmetric sweating dysfunction: A prospective quantitative study of patients with hemispheral brain infarction
58. Suppressed sympathetic skin response in brain infarction
59. Asymmetric skin temperature in ischemic stroke
60. Sexuality and sexual adjustment in stroke patients
61. Sexual functioning in stroke survivors
62. Sexuality after stroke with hemiplegia. I. Aspects of sexual function
63. Sexuality after stroke with hemiplegia. II. With special regard to partnership adjustment and to fulfillment
64. Sexual adjustment of men who have had strokes
65. Sexual dysfunction in stroke patients
66. Sexual changes in hemiparetic patients
67. Sexual dysfunction in stroke patients
68. A self-rating depression scale
69. The use of PotenTest in the multidisciplinary evaluation of impotence: Is it a reliable measure?
70. Nocturnal penile tumescence
71. Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment
72. An improved vasoactive drug combination for a pharmacological erection program
73. Vacuum constriction devices for erectile dysfunction: A long term, prospective study of patients with mild, moderate, and severe dysfunction
74. Female sexual dysfunction: Incidence, pathophysiology, evaluation, and treatment options
75. Safety and efficacy of sfidenafil in postmenopausal women with sexual dysfunction
76. Physical and functional assessment of the elderly stroke patient
77. Nocturia in adults: Etiology and classification
78. The pathophysiology of urinary incontinence among institutionalized elderly persons
79. Urodynamic evaluation of prostatic enlargements with micturitional vesicourethral static pressure profiles
80. A new temporary catheter (ContiCath) for the treatment of temporary, reversible, postoperative urinary retention
81. The North American experience with the Uro-Lume endoprosthesis as a treatment for symptomatic BPH: Long-term results
82. Uncommon complications of permanent stents
83. Benign prostatic hyperplasia: Diagnosis and treatment
84. Results of transurethral resection of prostate in patients with cerebrovascular disease
85. Nocturia
86. A novel therapy for nocturnal polyuria: A double-blind randomized trial of frusemide against placebo
87. Prophylactic treatment of adult nocturia with bumetanide
88. Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria
89. Desmopressin for the treatment of nocturnal polyuria in elderly subjects: A dose titration study
90. Oral desmopressin for nocturnal polyuria in elderly subjects: A double-blind, placebo-controlled, randomized exploratory study
91. Nocturnal enuresis provoked by an obstructive sleep apnea syndrome
92. A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia
93. Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: A double-blind, placebo-controlled, dose-response multicenter study
94. Clinical evaluation of tamsulosin, a prostate selective alphalc antagonist
95. Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: Pharmacodynamic effect
96. The North American experience with the Urolume endourethral prosthesis as a treatment for BPH: Three-year results
97. Permanent endoprostatic prostheses in patient with obstruction caused by benign hyperplasia of the prostate
98. Lower-energy thermotherapy in the treatment of benign prostatic hyperplasia: Long-term follow-up results of a multicenter international study
99. A prospective study of transperineal prostatic block for transurethral needle ablation for benign prostatic hyperplasia: The Emory University experience
100. Transurethral holmium laser resection of the prostate
101. The University of Tennessee experience with the Indigo 830e laser device for the minimally invasive treatment of benign prostatic hyperplasia: Interim analysis
102. Long-term follow-up in interstitial laser coagulation in benign prostatic hyperplasia treatment
103. A remote controlled intraurethral insert for artificial voiding: A new concept for treating women with voiding dysfunction
104. Cholinergic agonists
105. Voiding function: Relevant anatomy, physiology, pharmacology and molecular aspects
106. Is bethanechol chloride clinically effective in promoting bladder emptying? A literature review
107. The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: A randomized double-blind study
108. The effects of bethanechol chloride on urodynamic parameters in normal women and in women with significant residual urine volumes
109. Effect of metoclopramide on diabetic neurogenic bladder
110. Effects of cisapride on anorectal and vesicourethral function in spinal cord injured patients
111. Detrusor hyperactivity with impaired contractile function. An unrecognized but common cause of incontinence in elderly patients
112. Tolterodine
113. Tolterodine, a new antimuscarinic agent: As effective but better tolerated than oxybutynin in patients with an overactive bladder
114. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: A pooled analysis
115. Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin
116. Incontinence in elderly women: Is periurethral collagen an advance?
117. Collagen injection therapy for urinary incontinence
118. Summary of effectiveness and safety in the prospective, open, multicenter investigation of contigen implant for incontinence due to intrinsic sphincter deficiency in females
119. Transurethral collagen therapy in women
120. Endoscopic injection of glutaraldehyde cross-linked collagen for the treatment of intrinsic sphincter deficiency in women
121. Periurethral injection of collagen in the treatment of intrinsic sphincteric deficiency in the female patient
122. 3 Years experience with implantable micro-balloons for the treatment of intrinsic sphincter deficiency
123. Butch versus the pubovaginal sling
124. Pubovaginal fascial sling for all types of stress urinary incontinence: Long-term analysis
125. Pubovaginal fascial sling for the treatment of complicated stress urinary incontinence
126. Functional urethral closure with pubovaginal sling for destroyed female urethra after long term urethral catheterization
127. Pubovaginal sling procedure for stress incontinence
128. Modified pubo-vaginal sling in girls with myelodysplasia
129. Modified suburethral sling procedure for treatment of recurrent or severe stress urinary incontinence
130. Pubovaginal sling using cadaveric allograft fascia lata for the treatment of intrinsic sphincter deficiency
131. Pubovaginal sling using polypropylene mesh and Vesica bone anchors
132. Gore-Tex sling urethral suspension in type III female urinary incontinence: Clinical results and urodynamic changes
133. A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence
134. A three-year followup of tension free vaginal tape for surgical treatment of female stress urinary incontinence
135. Intermittent self-catheterization